Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.640
+0.130 (2.88%)
Mar 19, 2026, 4:00 PM EDT - Market closed
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 70 employees as of December 31, 2024. The number of employees increased by 14 or 25.00% compared to the previous year.
Employees
70
Change (1Y)
14
Growth (1Y)
25.00%
Revenue / Employee
$478,314
Profits / Employee
-$756,500
Market Cap
271.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 70 | 14 | 25.00% |
| Dec 31, 2023 | 56 | 11 | 24.44% |
| Sep 30, 2022 | 45 | - | - |
| Jun 30, 2022 | 42 | - | - |
| Mar 31, 2022 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Cellectis | 222 |
| C4 Therapeutics | 104 |
| OmniAb | 89 |
| Camp4 Therapeutics | 55 |
| Protara Therapeutics | 46 |
| ALX Oncology Holdings | 44 |
| Avalo Therapeutics | 23 |
OBIO News
- 7 days ago - Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update - GlobeNewsWire
- 16 days ago - Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT - GlobeNewsWire
- 4 weeks ago - Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewsWire
- 4 weeks ago - Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics - GlobeNewsWire
- 3 months ago - Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting - GlobeNewsWire
- 4 months ago - Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - GlobeNewsWire
- 4 months ago - Orchestra BioMed to Host Business Update Call on November 12, 2025 - GlobeNewsWire